Multimodal mass spectrometry imaging of mouse and human liver
小鼠和人类肝脏的多模态质谱成像
基本信息
- 批准号:10817566
- 负责人:
- 金额:$ 15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-10 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAdministrative SupplementAntibodiesArchitectureAtlasesCellsCellular StructuresChicagoCirrhosisData SetDatabasesDiseaseExtracellular MatrixFibrosisFutureHumanHuman BioMolecular Atlas ProgramIllinoisLiverMapsMetabolicModalityMolecularMultimodal ImagingMusNatureOrganPreparationPrimary carcinoma of the liver cellsProteomeProteomicsResolutionSamplingSignal TransductionSpatial DistributionStructureTimeTissuesUniversitiesVariantVisionVisualizationcell typedata integrationextracellularlipidomelipidomicsmass spectrometric imagingmetabolomemetabolomicsmetermultimodalitymultiple omicsprogramstechnology development
项目摘要
Project summary
We request an administrative supplement to build the first spatially-resolved 3D map of the human
liver integrating both cellular components and metabolites and the extracellular matrix for the first
time. This collaborative effort between the HuBMAP Transformative Technology Development
team led by Dr. Tian (University of Pittsburgh, Pitt) and Dr. Stockwell (Columbia University, CU)
and the Demonstration Program team led by Dr. Naba (University of Illinois Chicago, UIC) is in
line with HuBMAP’s vision for comprehensive organ mapping, providing an unprecedented view
into liver architecture with a depth never achieved before.
An extensive effort has been made to profile the extracellular matrix (ECM) composition – or
matrisomes – of various organs; however, there is still lack of study on the spatial distribution of
ECM components surrounding cells and contributing to functional multicellular structures, their
variation in normal vs. disease, and molecular signaling/crosstalk with cells. The challenges lie in
(1) the lack of panels of validated anti-ECM antibodies, (2) the difficulty in performing multiplexed
mapping of multi-level biomolecules at single-cell resolution, and (3) the difficulty to integrate
datasets generated using multiple “-omic” modalities in a single sample. The team led by Dr. Tian
developed a mass spectrometry imaging (H2O)n>25k-GCIB-SIMS dual-SIMS workflow, integrating
untargeted metabolomics, lipidomics, and targeted proteomics (up to 40 targets) on the same
tissue section at subcellular spatial resolution (1 µm). Together with the team led by Dr. Stockwell,
a robust multimodal imaging workflow has been established to generate a spatially-resolved atlas
of liver tissue, visualizing major tissue structures, cell types, and metabolic states of cell types.
Leveraging the draft of the human liver matrisome obtained by Dr. Naba and the content of
MatrisomeDB, the database of ECM proteomics datasets her team created, we propose to create
a spatially-resolved map of essential human liver matrisome components, along with our current
multiplexed liver map at the single-cell level.
This project will present a new opportunity to delineate the spatial organization of cellular and
extracellular biomolecules, the definition of functional tissue units, including information on
microenvironmental niches. This will allow, in the future, to define the nature of the interactions
and signals established between cells and their surrounding ECM, and to begin to understand
disease-associated dysregulations (e.g., fibrosis, cirrhosis, hepatocellular carcinoma).
项目摘要
我们要求行政补充,以建立第一个空间分辨率的三维地图的人类
肝脏整合细胞成分和代谢物以及细胞外基质,
时间HuBMAP转型技术开发部门与
由田博士(匹兹堡大学,皮特)和斯托克韦尔博士(哥伦比亚大学,CU)领导的团队
由Naba博士(伊利诺伊大学芝加哥分校,UIC)领导的演示计划团队在
符合HuBMAP的全面器官映射愿景,提供前所未有的视图
以前所未有的深度进入肝脏结构。
已经进行了广泛的努力来分析细胞外基质(ECM)组成-或
matrisomes -各种器官;然而,仍然缺乏对空间分布的研究,
细胞周围的ECM成分,并有助于功能性多细胞结构,其
正常与疾病的变化,以及与细胞的分子信号传导/串扰。困难在于
(1)缺乏经过验证的抗ECM抗体组,(2)进行多重检测的困难
以单细胞分辨率绘制多级生物分子,以及(3)难以整合
在单个样本中使用多个“组学”模态生成的数据集。田博士带领的团队
开发了质谱成像(H2O)n> 25 k-GCIB-西姆斯双SIMS工作流程,集成
非靶向代谢组学、脂质组学和靶向蛋白质组学(多达40个靶点)
亚细胞空间分辨率(1 µm)的组织切片。与斯托克韦尔博士领导的团队一起,
已经建立了一个强大的多模态成像工作流程,以生成空间分辨图谱
肝脏组织,可视化主要组织结构,细胞类型和细胞类型的代谢状态。
利用Naba博士获得的人类肝脏基质体草案和
MatrisomeDB是她的团队创建的ECM蛋白质组学数据集数据库,我们建议创建
一个基本的人类肝脏基质体成分的空间分辨图,沿着我们目前的
单细胞水平的多重肝脏图。
该项目将提供一个新的机会,描绘细胞的空间组织,
细胞外生物分子,功能组织单位的定义,包括信息
微环境生态位这将允许在未来定义相互作用的性质
以及细胞与其周围ECM之间建立的信号,并开始了解
疾病相关失调(例如,纤维化、肝硬化、肝细胞癌)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brent R Stockwell其他文献
Medical History takes a Partner
病史需要一个伙伴
- DOI:
- 发表时间:
2006 - 期刊:
- 影响因子:0
- 作者:
Cindy Voisine;Hemant Varma;Nicola Walker;Emily A. Bates;Brent R Stockwell;Anne C Hart - 通讯作者:
Anne C Hart
The role of iron and reactive oxygen species in cell death
铁和活性氧在细胞死亡中的作用
- DOI:
10.1038/nchembio.1416 - 发表时间:
2013-12-17 - 期刊:
- 影响因子:13.700
- 作者:
Scott J Dixon;Brent R Stockwell - 通讯作者:
Brent R Stockwell
Selective inhibitors of death in mutant huntingtin cells.
突变亨廷顿细胞死亡的选择性抑制剂。
- DOI:
- 发表时间:
2007 - 期刊:
- 影响因子:14.8
- 作者:
H. Varma;C. Voisine;C Todd DeMarco;E. Cattaneo;Donald C Lo;Anne C Hart;Brent R Stockwell - 通讯作者:
Brent R Stockwell
Advances in Protein Chemistry, Volume 65: Proteome Characterization and Proteomics
蛋白质化学进展,第 65 卷:蛋白质组表征和蛋白质组学
- DOI:
- 发表时间:
2004 - 期刊:
- 影响因子:10.4
- 作者:
Joseph Lehár;G. Zimmermann;Andrew S Krueger;Raymond A. Molnar;J. Ledell;Adrian M Heilbut;Glenn F Short;Leanne C Giusti;Garry P Nolan;O. Magid;Margaret S Lee;Alexis A. Borisy;Brent R Stockwell;Curtis T. Keith - 通讯作者:
Curtis T. Keith
mass spectrometry imaging reveals single-cell metabolic states in mammalian
质谱成像揭示哺乳动物的单细胞代谢状态
- DOI:
- 发表时间:
2022 - 期刊:
- 影响因子:0
- 作者:
Hua Tian;Presha Rajbhandari;Jay G. Tarolli;Aubrianna Decker;T. V. Neelakantan;Tina B. Angerer;Fereshteh Zandkarimi;Jacob D Daniels;Helen Remotti;Gilles Frache;Nicholas Winograd;Brent R Stockwell - 通讯作者:
Brent R Stockwell
Brent R Stockwell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brent R Stockwell', 18)}}的其他基金
Development of ferroptosis inhibitors for Huntington Disease
亨廷顿病铁死亡抑制剂的开发
- 批准号:
10461960 - 财政年份:2021
- 资助金额:
$ 15万 - 项目类别:
Development of ferroptosis inhibitors for Huntington Disease
亨廷顿病铁死亡抑制剂的开发
- 批准号:
10445418 - 财政年份:2021
- 资助金额:
$ 15万 - 项目类别:
Multimodal mass spectrometry imaging of mouse and human liver
小鼠和人类肝脏的多模态质谱成像
- 批准号:
10261546 - 财政年份:2020
- 资助金额:
$ 15万 - 项目类别:
Multimodal mass spectrometry imaging of mouse and human liver
小鼠和人类肝脏的多模态质谱成像
- 批准号:
10118811 - 财政年份:2020
- 资助金额:
$ 15万 - 项目类别:
Multimodal mass spectrometry imaging of mouse and human liver
小鼠和人类肝脏的多模态质谱成像
- 批准号:
10708966 - 财政年份:2020
- 资助金额:
$ 15万 - 项目类别:
Multimodal mass spectrometry imaging of mouse and human liver
小鼠和人类肝脏的多模态质谱成像
- 批准号:
10687346 - 财政年份:2020
- 资助金额:
$ 15万 - 项目类别:
Development of ferroptosis inhibitors for Huntington Disease
亨廷顿病铁死亡抑制剂的开发
- 批准号:
9810193 - 财政年份:2019
- 资助金额:
$ 15万 - 项目类别:
Defining the functions and translational potential of ferroptosis
定义铁死亡的功能和转化潜力
- 批准号:
10478855 - 财政年份:2016
- 资助金额:
$ 15万 - 项目类别:
Defining the functions and translational potential of ferroptosis
定义铁死亡的功能和转化潜力
- 批准号:
9978733 - 财政年份:2016
- 资助金额:
$ 15万 - 项目类别:
Defining the functions and translational potential of ferroptosis
定义铁死亡的功能和转化潜力
- 批准号:
9752242 - 财政年份:2016
- 资助金额:
$ 15万 - 项目类别:
相似海外基金
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
- 批准号:
10833895 - 财政年份:2023
- 资助金额:
$ 15万 - 项目类别:
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
- 批准号:
10841820 - 财政年份:2023
- 资助金额:
$ 15万 - 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
- 批准号:
10850135 - 财政年份:2023
- 资助金额:
$ 15万 - 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
- 批准号:
10896844 - 财政年份:2023
- 资助金额:
$ 15万 - 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
- 批准号:
10840220 - 财政年份:2023
- 资助金额:
$ 15万 - 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
- 批准号:
10844667 - 财政年份:2023
- 资助金额:
$ 15万 - 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
- 批准号:
10891050 - 财政年份:2023
- 资助金额:
$ 15万 - 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
- 批准号:
10711717 - 财政年份:2023
- 资助金额:
$ 15万 - 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
- 批准号:
10811292 - 财政年份:2023
- 资助金额:
$ 15万 - 项目类别:
Administrative Supplement: Genome Resources for Model Amphibians
行政补充:模型两栖动物基因组资源
- 批准号:
10806365 - 财政年份:2023
- 资助金额:
$ 15万 - 项目类别:














{{item.name}}会员




